StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Aastha Jain, Hem Securities

BUYMax Healthcare Institute Limited
Max Healthcare Institute share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: 1–3 months22 Jun 2026via Zee Business (Live)

Entry₹1,094.75Stated
Target₹1,200
Total upside +9.61% (call closed)
Stop loss₹1,010-7.74% risk
Exit₹1,01012 Aug 2026, 12:08 pm
Stop-loss hit-7.74%
Follow Aastha Jain for new calls(55% target hit, 20 closed calls)Get alertsWatch MAXHEALTH for new buy/sell callsGet alertsSee 1 active Short-term call on MAXHEALTH

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 12 Aug 2026
12 supporting3 neutral1 opposing
Supports the BUY call (12)

7 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · today

Max Healthcare Profit Rises 34% To ₹1,442 Crore In FY26

NewsGoogle News·30 Jul · 2w ago

(opens in new tab)

Max Healthcare Shares Trade Up 2% On Steady Growth Outlook

NewsGoogle News·27 Jul · 2w ago

(opens in new tab)

Max Healthcare Share Price: निवेशकों की बल्ले-बल्ले! कंपनी ने दिखाए दमदार ग्रोथ के संकेत, शेयर में आई **2%** की तेजी

NewsGoogle News·27 Jul · 2w ago

(opens in new tab)

Max Healthcare Share: 2% உயர்வு! வளர்ச்சி அவுட்லுக் வலுவாக உள்ளதா?

NewsGoogle News·27 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (3)

Max Healthcare Institute Limited disclosed an update on ongoing litigation concerning its subsidiary, Kalinga Hospital Ltd. The National Company Law Tribunal (NCLT) permitted the opposing party to rec

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·7 Aug · 4d ago

(opens in new tab)

Max Healthcare Institute Limited disclosed an update on petitions filed before the National Company Law Tribunal concerning Kalinga Hospital Ltd. The matter has been adjourned to August 4, 2026.

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·24 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

HDFC Life Falls 1.8% Despite 12% Profit Rise in Q1 FY27

NewsGoogle News·16 Jul · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Max Healthcare Institute

All analyst calls on Max Healthcare Institute

More from Aastha Jain, Hem Securities

Every call and its outcome